iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 52-Week High – Time to Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s stock price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $90.80 and last traded at $89.8810, with a volume of 42181 shares. The stock had previously closed at $90.36.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a fifty day moving average of $85.85 and a 200 day moving average of $77.95. The stock has a market cap of $1.01 billion, a price-to-earnings ratio of 17.75 and a beta of 0.54.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Large investors have recently made changes to their positions in the business. National Bank of Canada FI raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after purchasing an additional 175 shares during the last quarter. NBC Securities Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 46.5% in the fourth quarter. NBC Securities Inc. now owns 630 shares of the company’s stock valued at $53,000 after purchasing an additional 200 shares during the last quarter. U.S. Capital Wealth Advisors LLC grew its position in iShares U.S. Pharmaceuticals ETF by 2.8% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 7,608 shares of the company’s stock worth $645,000 after purchasing an additional 204 shares during the period. Wealthcare Advisory Partners LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 4.4% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 5,115 shares of the company’s stock valued at $371,000 after buying an additional 217 shares during the last quarter. Finally, TD Waterhouse Canada Inc. raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 34.9% during the 4th quarter. TD Waterhouse Canada Inc. now owns 870 shares of the company’s stock valued at $74,000 after buying an additional 225 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.